| Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy JW Jung, M Kwon, JC Choi, JW Shin, IW Park, BW Choi, JY Kim Yonsei medical journal 54 (5), 1293, 2013 | 232 | 2013 |
| VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers CG Kim, M Jang, Y Kim, G Leem, KH Kim, H Lee, TS Kim, SJ Choi, ... Science immunology 4 (41), eaay0555, 2019 | 180 | 2019 |
| Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability–high gastric cancer M Kwon, M An, SJ Klempner, H Lee, KM Kim, JK Sa, HJ Cho, JY Hong, ... Cancer discovery 11 (9), 2168-2185, 2021 | 176 | 2021 |
| Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy R Kim, M Kwon, M An, ST Kim, SA Smith, AB Loembé, PGS Mortimer, ... Annals of Oncology 33 (2), 193-203, 2022 | 88 | 2022 |
| Immune checkpoint inhibitors for cancer treatment J Park, M Kwon, EC Shin Archives of pharmacal research 39, 1577-1587, 2016 | 79 | 2016 |
| Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer HH Eum, M Kwon, D Ryu, A Jo, W Chung, N Kim, Y Hong, DS Son, ... Experimental & molecular medicine 52 (12), 1976-1988, 2020 | 73 | 2020 |
| TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer HS Han, S Jeong, H Kim, HD Kim, AR Kim, M Kwon, SH Park, CG Woo, ... Cancer letters 499, 137-147, 2021 | 59 | 2021 |
| Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer M Kwon, G Kim, R Kim, KT Kim, ST Kim, S Smith, PGS Mortimer, JY Hong, ... Journal for ImmunoTherapy of Cancer 10 (7), e005041, 2022 | 48 | 2022 |
| PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors M Kwon, CG Kim, H Lee, H Cho, Y Kim, EC Lee, SJ Choi, J Park, IH Seo, ... Clinical Cancer Research 26 (7), 1644-1655, 2020 | 41 | 2020 |
| Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer HM Shin, G Kim, S Kim, JH Sim, J Choi, M Kim, M Kwon, SK Ye, DS Lee, ... Nature communications 12 (1), 975, 2021 | 33 | 2021 |
| Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma AR Kim, SJ Choi, J Park, M Kwon, T Chowdhury, HJ Yu, S Kim, H Kang, ... Oncoimmunology 11 (1), 2026019, 2022 | 26 | 2022 |
| Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients SM Son, CG Woo, DH Kim, HY Yun, H Kim, HK Kim, Y Yang, J Kwon, ... Scientific Reports 10 (1), 14293, 2020 | 25 | 2020 |
| Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model JL Thangaraj, SY Ahn, SH Jung, MC Vo, TH Chu, MT Thi Phan, M Kwon, ... Cellular & Molecular Immunology 18 (7), 1652-1661, 2021 | 24 | 2021 |
| Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study JH Park, JY Hong, M Kwon, J Lee, K Han, IW Han, W Kang, JK Park European Journal of Cancer 150, 73-82, 2021 | 24 | 2021 |
| Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea H Kim, M Kwon, B Kim, HA Jung, JM Sun, SH Lee, K Park, MJ Ahn BMC cancer 20, 1-9, 2020 | 23 | 2020 |
| Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors M Kwon, BM Ku, S Olsen, S Park, M Lefterova, J Odegaard, HA Jung, ... Cancer medicine 11 (15), 2944-2956, 2022 | 21 | 2022 |
| Two-round mixed lymphocyte reaction for evaluation of the functional activities of anti-PD-1 and immunomodulators M Kwon, YJ Choi, M Sa, SH Park, EC Shin Immune network 18 (6), 2018 | 14 | 2018 |
| Association of serine/threonine kinase 11 mutations and response to programmed cell death 1 inhibitors in metastatic gastric cancer M Kwon, JY Hong, ST Kim, KM Kim, J Lee Pathology-Research and Practice 216 (6), 152947, 2020 | 13 | 2020 |
| Prevalence and predictive factors for upfront dose reduction of the first cycle of first-line chemotherapy in older adults with metastatic solid cancer: Korean cancer study … IG Hwang, M Kwon, JW Kim, SH Kim, YG Lee, JY Kim, SJ Koh, YH Ko, ... Cancers 13 (2), 331, 2021 | 7 | 2021 |
| Expression of immune checkpoint molecules on tumor infiltrating lymphocytes in glioblastoma multiforme J Park, M Kwon, KH Kim, JH Chang, EC Shin The Journal of Immunology 198 (1_Supplement), 196.3-196.3, 2017 | 7 | 2017 |
